This content is machine translated Hepatology and Metabolism The Mediterranean Diet for MASLD/MASH—What the EASL-EASD-EASO Guidelines Specifically Recommend Since an international Delphi consensus in 2023, the condition formerly known as nonalcoholic fatty liver disease (NAFLD) has been called MASLD— “metabolic dysfunction-associated steatotic liver disease.” It is defined as...…
View Post 15 min This content is machine translated MASH and heart health The underestimated cardiovascular threat Metabolic-associated steatohepatitis (MASH) was long considered a purely hepatic problem. Today, data from large clinical trials and registries clearly show that cardiovascular disease is the most common cause of death...…
View Post 6 min This content is machine translated MASLD often goes unnoticed and is underestimated Think tank for improving the supply situation Metabolic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), can lead to serious complications. Non-invasive diagnostics and AI-supported screening have the potential to facilitate early detection in...…
View Post 12 min This content is machine translated Liver steatosis with metabolic dysfunction New nomenclature for non-alcoholic fatty liver disease The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...… CME-Test
View Post 12 min This content is machine translated Liver steatosis with metabolic dysfunction New nomenclature for non-alcoholic fatty liver disease The term “non-alcoholic steatohepatitis” (NASH) was originally used to describe liver damage characterized by lobular inflammation, steatosis and ballooning of hepatocytes. In addition, a large proportion of patients were described...… CME-Test
View Post 4 min This content is machine translated From symptom to diagnosis Abdominal pain – Steatosis hepatis In steatotic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are distinguished from alcoholic fatty liver disease (AFLD) and alcoholic steatohepatitis (ASH) from an etiological point of…
View Post 4 min This content is machine translated Fibrosis (FIB)-4 score Screening at-risk patients for NAFLD Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease. The FIB-4 score can be used to identify at-risk patients with NAFLD and, if necessary, refer them…
View Post 3 min This content is machine translated Fatty liver disease New widespread disease NAFLD Model calculations suggest that the number of patients with cirrhosis, advanced fibrosis, or hepatocellular carcinoma (HCC) could double to triple in the next 10-15 years. Not least because of this,…
View Post 5 min This content is machine translated Non-alcoholic fatty liver disease (NAFLD) What does the current guideline say? Non-alcoholic fatty liver disease is the most common liver disease worldwide. The German S2k guideline, updated in 2022, recommends screening patients at risk. The proposed screening algorithm includes fibrosis assessment…
View Post 11 min This content is machine translated Non-alcoholic fatty liver disease (NAFLD) Underdiagnosed and underestimated Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western world. In distinction to alcoholic fatty liver disease, alcohol consumption in NAFLD should be at a… CME-Test
View Post 3 min This content is machine translated Non-alcoholic fatty liver disease (NAFLD) No pill will help… The term non-alcoholic fatty liver disease encompasses a spectrum of findings ranging from simple steatosis or fatty liver to steatohepatitis as an inflammatory form to liver fibrosis and cirrhosis. There…
